Literature DB >> 16111911

Delirium in Parkinson's disease patients. a five-year follow-up study.

Marcos Serrano-Dueñas1, María J Bleda.   

Abstract

OBJECTIVE: To assess the significance of delirium in parkinsonian patients in a 5-year follow-up case-control study with three groups of patients: Parkinsonian and Delirium (PDG), Parkinsonian (PG) and Control (CG).
METHODS: Comparisons of Short Test of Mental Status (STMS) and Unified Parkinson's Disease Rating Scale-motor section (UPDRS(m)) between groups were performed using analysis of variance with repeated measurements. Comparisons of survival functions and Cox regression models were used to analyse the time until death.
RESULTS: STMS and UPDRS(m) mean scores were statistically different between PDG group and the other two groups (p < 0.001) and between PDG and PG groups (p < 0.001), respectively. Including all groups, PG's patients (HR = 0.29; 95% C.I. = 0.09-0.93) and CG's patients (HR = 0.13; 95% C.I. = 0.03-0.60) had less hazard to die than PDG's patients; patients with a STMS basal score >33 (HR = 0.37; 95% C.I. = 0.13-0.99) had less hazard to die than patients with a score < or =33. Finally, including PDG and PG groups, patients with basal UPDRS(m) score >17 (HR = 4.88; 95% C.I. = 1.11-21.48) had higher hazard to die than patients with a score < or =17.
CONCLUSION: For patients with Parkinson's, delirium is an increased risk factor for developing dementia, to have a more severe motor impairment and to death.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16111911     DOI: 10.1016/j.parkreldis.2005.05.002

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  7 in total

Review 1.  The practical management of cognitive impairment and psychosis in the older Parkinson's disease patient.

Authors:  John V Hindle
Journal:  J Neural Transm (Vienna)       Date:  2013-02-22       Impact factor: 3.575

Review 2.  Review of delirium in patients with Parkinson's disease.

Authors:  Emma R L C Vardy; Andrew Teodorczuk; Alison J Yarnall
Journal:  J Neurol       Date:  2015-05-10       Impact factor: 4.849

Review 3.  Management of delirium in Parkinson's disease.

Authors:  Georg Ebersbach; Chi Wang Ip; Stephan Klebe; Jiri Koschel; Stefan Lorenzl; Christoph Schrader; Christian Winkler; Christiana Franke
Journal:  J Neural Transm (Vienna)       Date:  2019-02-06       Impact factor: 3.575

4.  Olfactory dysfunction is related to postoperative delirium in Parkinson's disease.

Authors:  Min Seung Kim; Jung Han Yoon; Hyun Jae Kim; Seok Woo Yong; Ji Man Hong
Journal:  J Neural Transm (Vienna)       Date:  2016-04-20       Impact factor: 3.575

5.  Identifying delirium in Parkinson disease: A pilot study.

Authors:  Rachael A Lawson; Sarah J Richardson; Alison J Yarnall; David J Burn; Louise M Allan
Journal:  Int J Geriatr Psychiatry       Date:  2020-02-07       Impact factor: 3.485

Review 6.  Delirium after Deep Brain Stimulation in Parkinson's Disease.

Authors:  Hanyi Li; Shunchang Han; Juan Feng
Journal:  Parkinsons Dis       Date:  2021-02-01

7.  Why is there motor deterioration in Parkinson's disease during systemic infections-a hypothetical view.

Authors:  Florian Brugger; Roberto Erro; Bettina Balint; Georg Kägi; Paolo Barone; Kailash P Bhatia
Journal:  NPJ Parkinsons Dis       Date:  2015-08-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.